KA
TMDX icon

Kovack Advisors’s Transmedics TMDX Stock Holding History

Kovack Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,200
Closed -$304K – 766
2021
Q3 		$304K Buy
9,200
+1,900
+26% +$58.1K 0.03% 523
2021
Q2 		$242K Sell
7,300
-500
-6% -$13.9K 0.03% 577
2021
Q1 		$324K Buy
+7,800
New +$240K 0.04% 433

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Kovack Advisors's TMDX Position: Q4 2021 in Review

Kovack Advisors sold out of Transmedics (TMDX) in Q4 2021, closing a stake of 9,200 shares — an estimated $304K sold.

Kovack Advisors first reported a position in TMDX in Q1 2021 and held it in 3 quarters. The position peaked at $324K in Q1 2021. 121 funds tracked by Wall St. Rank hold TMDX as of Q4 2021.

  • Kovack Advisors reported no remaining Transmedics position as of Q4 2021 after selling out during the quarter.
  • Kovack Advisors sold 9,200 Transmedics shares in Q4 2021, an estimated $304K.
  • Kovack Advisors first reported a position in Transmedics in Q1 2021 and held it in 3 quarters.
  • Kovack Advisors's Transmedics position peaked at $324K in Q1 2021.
  • 121 funds tracked by Wall St. Rank held Transmedics as of Q4 2021.

Based on Kovack Advisors's 13F filing for Q4 2021, filed 18 Jan 2022.